The heterogeneous nature of mammalian PRC1 complexes has hindered our understanding of their biological functions. Here, we present a comprehensive proteomic and genomic analysis that uncovered six major groups of PRC1 complexes, each containing a distinct PCGF subunit, a RING1A/B ubiquitin ligase, and a unique set of associated polypeptides. These PRC1 complexes differ in their genomic localization, and only a small subset colocalize with H3K27me3. Further biochemical dissection revealed that the six PCGF-RING1A/B combinations form multiple complexes through association with RYBP or its homolog YAF2, which prevents the incorporation of other canonical PRC1 subunits, such as CBX, PHC, and SCM. Although both RYBP/YAF2-and CBX/PHC/SCM-containing complexes compact chromatin, only RYBP stimulates the activity of RING1B toward H2AK119ub1, suggesting a central role in PRC1 function. Knockdown of RYBP in embryonic stem cells compromised their ability to form embryoid bodies, likely because of defects in cell proliferation and maintenance of H2AK119ub1 levels.
INTRODUCTION
Polycomb-group (PcG) genes, which were originally identified in Drosophila melanogaster as developmental regulators of body segmentation through Hox gene repression (Lewis, 1978; Struhl, 1981) , are crucial for many biological processes in mammals, including stem and differentiation, and cancer (Jaenisch and Young, 2008; Margueron and Reinberg, 2011; Sparmann and van Lohuizen, 2006) . PcG proteins assemble in multisubunit nuclear complexes with various biochemical functions, including recognition and modification of histone posttranslational modifications (PTMs) and chromatin compaction (Simon and Kingston, 2009 ). The two most studied PcG complexes are Polycomb Repressive Complex 1 (PRC1) and 2 (PRC2), which catalyze two repressive histone PTMs: monoubiquitination of histone H2A at lysine-119 (H2AK119ub1) and methylation of histone H3 at lysine-27 (H3K27me), respectively (Margueron and Reinberg, 2011; Simon and Kingston, 2009) .
Since their discovery, PRC1 and PRC2 have been the objects of extensive biochemical investigation (Vidal, 2009) , genetic dissection (Grimaud et al., 2006) , and genomic analysis (Ringrose, 2007) , which have unveiled the complexity and diversity of the mammalian counterparts of these protein complexes. Mammalian PRC1 complexes are very heterogeneous because each of the Drosophila subunits has several homologs in the human genome and they can associate in a combinatorial fashion. In Drosophila, the core PRC1 complex (Saurin et al., 2001; Shao et al., 1999) contains Polycomb (Pc), a chromodomain-containing protein that binds to H3K27me3 (Fischle et al., 2003; Min et al., 2003) ; dRing, the enzyme responsible for H2A ubiquitination (Wang et al., 2004) ; Posterior sex combs (Psc), which is responsible for chromatin compaction in vitro (Francis et al., 2004); and Polyhomeotic (Ph) . Additional components are found associated with PRC1 in substoichiometric amounts, such as the PcG protein Sex Comb on Midleg (Scm). The initial mammalian PRC1 (henceforth, canonical PRC1) purified from HeLa cells contained various chromodomain proteins (CBX) homologous to Pc; enzymes similar to dRing, called RING1A and RING1B; three Ph homologs (PHC1-3); BMI1/PCGF4, one of six human Psc homologs that are known collectively as Polycomb group RING fingers (PCGFs); and substoichiometric amounts of SCMH1, an Scm homolog (Levine et al., 2002) . Combinatorial association of these different PcG homologs likely give rise to functionally distinct PRC1 complexes in humans. In fact, purification of BcoR-and L3MBTL2-associated polypeptides identified different PRC1-related complexes that, instead of PCGF4, contained NSPC1/PCGF1 and MBLR/PCGF6, respectively, together with other factors (Gearhart et al., 2006; Trojer et al., 2011) .
Genetic evidence suggests that the canonical PRC1 is required for transcriptional repression (Simon and Kingston, 2009 ). Genome-wide target analysis in embryonic stem cells (ESCs) revealed that PRC1 and PRC2 complexes localize to the promoters of developmental regulators Lee et al., 2006) , suggesting that one function of PRCs is to maintain the pluripotency of embryonic stem cells (ESC) through silencing of differentiation genes. One current model for PRC1 recruitment at target genes posits that H3K27me functions as a recruitment signal through binding of Pc/CBX (Simon and Kingston, 2009 ); however, cases of H3K27me-independent localization have also been reported (Pasini et al., 2007; Schoeftner et al., 2006; Trojer et al., 2011) .
From a mechanistic perspective, two molecular functions have been attributed to PRC1: chromatin compaction (Levine et al., 2002; Shao et al., 1999) and H2AK119 monoubiquitination (Wang et al., 2004) . Some noncanonical PRC1, the BcoR complex, and the L3MBTL2 complex also catalyze H2AK119 monoubiquitination (Gearhart et al., 2006; Trojer et al., 2011) . In addition, L3MTBL2 compacts chromatin in vitro (Trojer et al., 2011) . With even more such complexes expected to exist, a systematic study is needed to clarify the physical interrelationship among all PRC1 complexes, as well as their activities.
The most recent additions to the family of human PRC1 complex components are RING1/YY1-binding protein (RYBP) and its homolog, YAF2 (Vidal, 2009) . These proteins bind to RING1A/B and YY1 (García et al., 1999; Kalenik et al., 1997) , the mammalian homolog of Drosophila Pho that is required for the recruitment of PRC1/2 to certain Polycomb response elements (PRE) in Drosophila (Simon and Kingston, 2009 ). Because of the potential interaction of RYBP/YAF2 with YY1, it has been proposed that RYBP/YAF2 might serve as mediators to bridge PRC1 to YY1 for their recruitment (Wilkinson et al., 2010; Woo et al., 2010) ; however, their precise role in the context of human PRC1 function remains unknown.
To clarify and distinguish the functions of the different mammalian PRC1 complexes, we have undertaken a comprehensive proteomic and genomic approach. All PRC1 complexes identified by our approach contain RING1A/B, but they fall into six different groups, based on which PCGF they contain. Genome-wide target analysis revealed that different PRC1 complexes have distinct genomic localizations, indicating the existence of a sophisticated recruitment program that depends on the subunit composition of the individual complexes. Interestingly, RYBP or its homolog, YAF2, is found in most PRC1 complexes except those containing CBXs, PHCs, and SCMs. Biochemical and genomic analyses demonstrated a critical role of RYBP in the function of PRC1, and depletion of RYBP in ESCs led to a defect in embryoid body formation that correlated with compromised cell proliferation and loss of H2A monoubiquitination.
RESULTS

Proteomic Profiling of the Family of PRC1 Complexes
To determine the composition of the various PRC1 complexes in human cells, we performed tandem affinity purification (TAP) from 293TREx cells stably expressing doxycycline-inducible NSPC1/PCGF1, MEL18/PCGF2, PCGF3, BMI1/PCGF4, PCGF5, MBLR/PCGF6, or RING1B, each fused with sequential N-terminal FLAG and HA tags (NFH). To minimize nonspecific binding and other overexpression artifacts, we induced expression of the tagged proteins at levels comparable with their endogenous counterparts (Figure S1A available online). TAP immunoprecipitates were subjected to mass spectrometry (MS) to determine associated polypeptides ( Figure 1A ). Two central observations emerged from this initial analysis: 1) all PRC1 complexes contain RING1A and RING1B ( Figure 1A , lanes 1-6), enzymes that catalyze H2AK119ub1, and 2) the critical determinant of PRC1 complex identity is the type of PCGF protein ( Figure 1A , lanes 1-6, and see below). In other words, all PCGFs were recovered in the RING1B TAP but, in each individual PCGF TAP, no other PCGF was found ( Figure 1A , lanes 1-7), indicating that each PCGF pairs with RING1B in an exclusive manner. In turn, each PCGF associated with different polypeptides ( Figure 1A , lanes 1-6), with the exception of PCGF2 and PCGF4, which appeared to form relatively similar complexes. Although some of the proteins identified by our proteomic analysis were already known as PRC1 components (Vidal, 2009 ), many had not been previously recovered. For example, TAPs for the previously uncharacterized PCGF3 and PCGF5 recovered AUTS2, FBRS, and FBRSL1, which have no known relationship with PRC1 ( Figure 1A , lanes 3 and 5). Some of the factors identified by MS were confirmed by western blotting ( Figure S1B ). In light of these results, we conducted a second round of TAPs for NFH-RYBP, -YAF2, -CBX2/4/6, and -PHC1-3. The network of interactions obtained through this extensive TAP-MS approach revealed the existence of six groups of PRC1 complexes ( Figures 1A and 1C) . To reflect the specific association of each PCGF with core PRC1 components and different sets of polypeptides, we will refer to these six groups of PRC1 complexes as PRC1.1, PRC1.2, PRC1.3, PRC1.4, PRC1.5, or PRC1.6 according to their PCGF subunit (PRC1.1 contains PCGF1, PRC1.2 contains PCGF2, and so on). The association of additional proteins with various PCGFs is, for the most part, exclusive but they are all recovered from RING1B pull-down ( Figure 1A , lane 7). The conclusion that PCGF determines distinct complexes is further supported by the results of immunoprecipitation (IP) experiments in 293T cells, showing that distinct PCGFs interact with their specific partners ( Figure 1B) . The presence of RING1A in all PRC1 complexes was also confirmed by co-IP ( Figure S1C ). As a specificity control, YY1, which was not recovered in our TAPs, did not interact with any of the PRC1 components tested (Figures 1B and S1C) .
In addition to RING1A/B, RYBP and YAF2 copurified with all PCGFs ( Figure 1A, lanes 1-6) . The presence of RYBP in PRC1 complexes was further confirmed by co-IP experiments using RING1A, RING1B, RYBP, PCGF1, PCGF2, PCGF4, and PCGF6 antibodies ( Figures 1B and S1C) . Interestingly, the presence of RYBP or YAF2 in PRC1.2 and PRC1.4 complexes excluded canonical components, such as CBXs, PHCs, and SCMs ( Figure 1A) , which is consistent with the finding that CBX2 did not coimmunoprecipitate with RYBP ( Figure 1B , left). This suggests that, at least in the case of PRC1.2 and PRC1.4, two subtypes of complexes are formed, one with canonical PcG components (CBXs, PHCs, and SCMs) and one with either RYBP or YAF2 ( Figure 1A ). RYBP and YAF2 are also mutually exclusive, given that TAP of RYBP did not recover YAF2 and vice versa ( Figure 1A, lanes 14 and 15) . The widespread presence of RYBP and YAF2 indicates that they play a critical role in the function of PRC1 complexes. In fact, inclusion or exclusion of RYBP/YAF2 results in additional heterogeneity within the six PRC1 complex groups, as evidenced by glycerol gradient fractionation followed by MS analysis ( Figure S2 ).
Although the above results were obtained in 293T-REx cells, some of the interactions (e.g., those identified by NFH-RING1B and NFH-PCGF1 TAPs) were verified by co-IP in murine ESCs ( Figure S1D ), suggesting that this intricate network of PRC1 complexes is conserved among different cell types and evolutionarily related organisms and are not a peculiarity of the cell line or the affinity tags utilized in our experiments.
In summary, our proteomic analysis demonstrates the existence of an extended family of PRC1 complexes in human cells ( Figure 1C) , characterized by the conserved presence of a RING1A/B ( Figures 1A and S1C ) subunit, likely conferring H2A ubiquitinating activity to all members. The PRC1 family can be divided into at least six groups, referred to here as PRC1.1-1.6 ( Figure 1C ), based on the identity of the PCGF subunit. Within each group, further complexity can be revealed by more in-depth biochemical analysis (see below). RYBP (or its homolog,YAF2) associates with all groups of PRC1 complexes, suggesting a central role in PRC1 function. However, at least in the case of PRC1.2 and PRC1.4, incorporation of RYBP/YAF2 is accompanied by the loss of other protein subunits (CBXs, PHCs, and SCMs). This variety of complexes and their heterogeneous 293T-REx cells expressing the Flag-HA-tagged PRC1 subunit indicated at the top of the table were lysed and interacting polypeptides were recovered by sequential FLAG-HA affinity purification (TAP). The final eluate was subjected to liquid chromatography-mass spectrometry (LC-MS), and the spectrum count of each protein is color-coded and displayed as a heat map, with more intense color representing more abundant species. Polypeptides are grouped according to which PCGF they associate with (referred to as PRC1.1-1.6, as indicated on the left). (B) IP from 293T nuclear extracts (NE) using antibodies for RING1B, RYBP, PCGF4, PCGF1, PCGF2, and PCGF6. Bound proteins were resolved on SDS-PAGE and detected by western blotting for the indicated antigens. (C) Schematic depiction of PRC1 family complexes. See text for details. composition likely provide a platform for the diverse functions of PRC1 in vivo.
Different PCGFs Occupy Distinct Genomic Loci
Having profiled the subunit composition of the different PRC1 complexes, we sought to investigate their genomic localization by chromatin IP, followed by deep sequencing (ChIP-seq). We performed ChIP with anti-HA antibodies (HA ChIP-seq) on extracts from 293T-REx cell lines after inducing expression of NFH-RING1B, -RYBP, -PCGF1, -PCGF2, -PCGF4, -PCGF5, -PCGF6, and -CBX2. Because H3K27me3 and H2AK119ub1 are commonly associated with Polycomb function (Simon and Kingston, 2009) , we also performed ChIP for these chromatin marks.
Consistent with the role of PRC1 in regulating gene expression, all analyzed PRC1 components were predominantly found in the 10 kb region surrounding transcriptional start sites (TSS) ( Figure S3 ), which prompted us to narrow our subsequent analyses to these regions.
Confirming our biochemical observations, we found several examples of promoters bound exclusively-or predominantlyby only one PCGF ( Figure 2A ). As expected, most of these loci were also bound by RING1B and RYBP, regardless of which PCGF was present ( Figure 2A ). To extend this observation to the whole genome, we identified significantly enriched regions (SERS, p <0.01) using an in-house developed peak caller (Asp et al., 2011) and calculated the percentage of target genes shared by RING1B and PCGFs. SERs for RING1B were found (C) GO biological process and mouse phenotype analysis of the targeted genomic regions identified in PCGF1, PCGF2, PCGF4, PCGF5, and PCGF6 ChIP-seq, using GREAT (McLean et al., 2010) . The x axis (in logarithmic scale) corresponds to the binomial raw p values.
at most (58%-74%) genes targeted by PCGF1/2/4/5/6 (Figure 2B , highlighted box). The fraction of genes targeted by more than one PCGF was much smaller, ranging from 12% to 31% ( Figures S4A and S4B) , consistent with our biochemical observations that RING1B is a key component of all PRC1 groups, whereas each PCGF forms distinct complexes ( Figures  1A and 1C) .
Despite some overlap in gene targets by different PCGFs, the functional terms associated with PCGF-enriched regions according to GREAT (McLean et al., 2010) were very different ( Figure 2C ), suggesting that the chromatin distribution of each PCGF reflects functional differences. PCGF1 target genes were enriched for gene ontology (GO) terms including cell junction organization and striated muscle-cell differentiation; PCGF2 targets were enriched for terms such as epithelial cell differentiation and embryonic pattern specification; PCGF4 targets were enriched for terms related with translation and metabolism; PCGF5 targets were related with mouse phenotypes like decreased startle reflex and abnormal muscle relaxation; and PCGF6 targets were enriched for mouse phenotype like abnormal vaginal opening/morphology.
To ensure that the NFH-tagged PRC1 components recapitulate the chromatin distribution of their endogenous counterparts, ChIP were also performed using antibodies against RING1B, RYBP, PCGF4, and CBX2 (endogenous ChIP-seq) in 293T-REx cells. At many locations, distribution profiles for endogenous PRC1 components mirrored the profiles that we obtained by HA ChIP-seq ( Figure S4C ).
CBX2-Containing PRC1.2 and PRC1.4 Accumulate at H3K27me3-Rich Regions
Because a popular mechanistic model for PRC1 recruitment envisions a central role for H3K27me3, we analyzed the correlation between the presence of this chromatin mark and the binding of different PRC1 complexes. Only a small subset of PRC1 targets overlapped with H3K27me3-rich regions and those were typically bound by complexes containing CBX2, PCGF2, and/or PCGF4 (Figures 2A and 3A) . This observation is in contrast with the extensive overlap between RING1B and H3K27me3 reported in ESCs Ku et al., 2008) but consistent with other studies that reported H3K27me3-independent recruitment of PRC1 to chromatin (Pasini et al., 2007; Schoeftner et al., 2006; Trojer et al., 2011) . PRC1.1, PRC1.5, and PRC1.6 SERs were mostly devoid of H3K27me3 (Figures 2A and 3A) , and even among PRC1.2 and 1.4 SERs, the majority was devoid of any discernible H3K27me3 signal, which was almost exclusively detected in CBX2 SERs ( Figure 3A) . Consistent with this observation, a correlation study of the top 1,000 RING1B SERs revealed distinct clusters of PRC1 components and a preferential association of H3K27me3 with CBX2 ( Figure 3B ). In fact, negative Pearson correlation coefficients between the ChIP-seq signal for PCGF1, 5, and 6 and that of H3K27me3 suggest that this mark may be slightly depleted from regions bound by PRC1.1, PRC1.5, and PRC1.6 ( Figure 3B) . The difference in H3K27me3 density between the top 50 SERs co-occupied by RING1B and each PCGF was also evident when we measured the normalized number of H3K27me3 reads ( Figure 3C ). In keeping with this, the distribution of L3MBTL2 (a PRC1.6 component) in K562 cells showed no correlation with H3K27me3 (Trojer et al., 2011) .
We conclude that H3K27me3-rich regions are mostly occupied by PRC1.2 and PRC1.4, possibly via the interaction of CBX2 or other CBX proteins with H3K27me3 (Bernstein et al., 2006; Kaustov et al., 2011 ). This conclusion is consistent with our biochemical data showing that only PRC1.2 and PRC1.4 associate with CBXs, which is known to bind the H3K27me3 mark.
In contrast to H3K27me3, we found that H2AK119ub1 was enriched on SERs for all PCGFs (Figure 2A ). However, we noted a similarity in the distribution of the RYBP and H2AK119ub1 ChIP-seq signal (Figures 2A and 3E) , and we found that within the top RING1B (2,000 for HA-tagged and 200 for endogenous) SERs, those also occupied by RYBP displayed increased intensity of H2AK119ub1 ChIP-seq signal ( Figure 3D ), suggesting the possibility that RYBP may facilitate the deposition of the ubiquitin mark in these regions (see below).
Differences in the Local Binding Profile of RYBP and CBX Proteins
According to our biochemical purification, PRC1 complexes contain either RYBP or CBXs but not both ( Figure 1A, lanes  8-15) . Therefore, we were surprised to find that RYBP and CBX2 are often found in the vicinity of the same genes ( Figure 2A ) and that the distributions of these two proteins on chromatin seemed correlated ( Figure 3B ). However, we noticed that in many cases their binding profile to the same promoter differed greatly ( Figure 3E ). For example, at the CCND2 promoter, CBX2 accumulates upstream of the broad RYBP peak, with minimal overlap. Similarly, on the RUNX1 locus, although the bound regions of RYBP and CBX2 overlap partially, their peak shapes are quite different ( Figure 3E ). These differences would not have been detected by the gene target and genome-wide correlation analyses, which function on relatively large genome windows. To generalize this observation, we analyzed the extent of overlap at the single-nucleotide level between all RING1B-, PCGF2-, PCGF4-, and RYBP-enriched regions that co-occupied with CBX2 ( Figure 3F, bottom) . Most of the RYBP-enriched regions overlap by less than 30% with CBX2-enriched regions, whereas a majority of PCGF2-and PCGF4-enriched regions overlap by 80% or more with CBX2. This suggests that at many promoters RYBP-and CBX-containing PRC1 complexes ( Figure 3F , top) coexist by binding to adjacent yet separate regions. Importantly, this is not the case for RING1B and other PCGFs. Thus, although RYBP and CBX form mutually exclusive complexes, these complexes at times occupy the same genomic regions, but with distinct binding profiles.
Further Characterization of PRC1.2/1.4 Complexes
To better decipher the relationship between RYBP/YAF2 and the other subunits in the PRC1.2 and PRC1.4 complexes, we fractionated RING1B-containing complexes by differential centrifugation on a 15%-35% glycerol gradient ( Figure S2A) . After a major peak in fraction 5-7, RING1B and PCGF4 were present throughout the gradient, whereas the distribution of RYBP/ YAF2 and CBX4/CBX8 did not overlap ( Figure 4A ). This result confirmed that RYBP/YAF2 and CBX4/CBX8 form separate yet 
Subcomplexes
(A) Glycerol gradient analysis of FLAG-purified RING1B complexes. Every other fraction from a 15%-35% glycerol gradient was further purified on HA-beads and resolved on SDS-PAGE, followed by immunoblotting for the indicated antigens. (B) IP of FLAG-purified RING1B complexes by antibodies against RYBP, PHC3, and control IgG. The bound proteins were run on SDS-PAGE and detected with the indicated antibodies. (C) Competitive binding assay to test the interaction of FLAG-RING1B with HA-RYBP and HA-CBX8. HA-CBX8 was incubated with FLAG-RING1B in the absence or presence of HA-RYBP and precipitated with FLAG-beads. The bound fraction was resolved on SDS-PAGE and specific proteins were revealed by western blot using HA and RING1B antibodies. stable complexes with RING1B and PCGF4, as suggested by the proteomic analysis (Figure 1A, lanes 8-15) . IPs of FLAG-purified RING1B complexes confirmed that RYBP and PHC3 do not interact with each other, although they both interact with RING1B ( Figure 4B ). Consistent with the proteomic results ( Figure 1A ), CBX4 coimmunoprecipitated with PHC3 ( Figure 4B ).
Our finding that RING1A/B, PCGF4, or PCGF2 form independent complexes with RYBP or YAF2, distinct from the canonical PRC1 complex, is consistent with the report that CBX7 (one of the PRC1-related CBX proteins) and RYBP bind to the same surface on the C-terminal domain of RING1B . Indeed, RYBP inhibited in a dose-dependent manner the binding of CBX8 to RING1B ( Figure 4C ), suggesting that RYBP and probably its homolog, YAF2, compete for the same RING1A/B binding site with CBXs and are potentially required at different times or for different aspects of PRC1 function ( Figure 4D ).
Functional Comparison of RYBP-and CBX/PHCContaining PRC1 Complexes
How PRC1 complexes enforce transcriptional repression remains poorly understood. Proposed mechanisms include compaction of chromatin and placement of a repressive mark, H2AK119ub1 (Simon and Kingston, 2009) . We decided to focus on PRC1.4 and sought to determine how inclusion or exclusion of its different subunits affects its abilities to compact chromatin and to catalyze H2AK119ub1.
We isolated PRC1.4 by FLAG-purification from NFH-PCGF4-containing extracts and separated the complexes containing RYBP/YAF2 (fractions RYBP/YAF2) or CBX/PHC/SCM (fractions CBX/PHC) through differential centrifugation ( Figure 5A ). Incubation of either complex with a nucleosomal array caused a comparable shift of the array toward high molecular-weight fractions in sucrose gradients ( Figure 5B ), suggesting that the shift mediated by PRC1.4 is not affected by the presence or absence of RYBP, CBX2, and PHC3. No differences were observed when the nucleosomal arrays were reconstituted with recombinant or native histones ( Figure 5B) , consistent with the observation that histone PTMs are not required for PRC1-mediated compaction (Francis et al., 2004) . Recombinant PCGF4 did not affect the migration of the arrays on the gradient, whereas L3MBTL2 shifted it, consistent with our previous findings (Trojer et al., 2011) . Electron microscopy (EM) analysis showed that the normal beads-on-a-string morphology of nucleosomal arrays was (E) Reconstituted complexes were used in an in vitro nucleosomal H2A monoubquitinylation assay (Experimental Procedures). The reactions were resolved on SDS-PAGE, followed by immunoblotting. The top two panels show the monoubiquitinated H2A detected by a specific H2AK119ub1 antibody and an H2A antibody, respectively. Components of reconstituted complexes were also shown by western blotting using antibodies against RING1B, RYBP, CBX2, and CBX8, respectively. Note that multiple bands migrate above RING1B, representing ubiquitinated forms of RING1B. Ponceau staining of histones is shown at the bottom. (F) Effects of RYBP on E3 ligase activity of reconstituted RING1B-PCGF4 complex toward H2AK119. Varying amounts of RYBP purified from insect cells were used in the in vitro H2A monoubquitinylation assay as in (E), and H2AK119ub1 was detected by immunoblotting. converted to a more compacted structure upon preincubation with both complexes, albeit the one containing CBX/PHC/ SCMs showed a slightly more closed structure ( Figure 5C ).
To test whether the in vitro chromatin compaction activity of these PRC1 complexes recapitulates in vivo phenomena, an in situ chromatin accessibility assay was performed on several PRC1-bound loci. The high rate of nuclease protection showed that three of these loci (C16ORF5, CCND2, and RUNX1) adopt a compacted chromatin state ( Figure S5 ), similar to that of known compacted loci such as RHO and SYN1. Therefore, at least at a subset of PRC1 target loci, chromatin is in a compacted configuration.
We next asked whether the presence of the RYBP versus CBX/PHC subunits affected the ubiquitinating activity of PRC1.4 with reconstituted complexes purified from insect cells ( Figure 5D , left). To our surprise, RYBP-containing RING1B-PCGF4 complexes exhibited stronger enzymatic activity than those containing PHC2 and either CBX2 or CBX8 ( Figure 5E ). This was due, at least in part, to the dose-dependent stimulatory effect of RYBP on a preformed RING1B-PCGF4 heterodimer ( Figure 5F ). These data suggest that human RYBP stimulates the activity of RING1B on H2AK119.
RYBP Is Required for ESC Differentiation, Cell
Proliferation, and Maintenance of H2AK119ub1 In Vivo So far, we have established RYBP as a major component of PRC1 family complexes and identified a group of previously uncharacterized complexes containing RYBP or YAF2, together with RING1A/B and PCGFs. We next asked what role RYBP might play in the context of a critical PRC1 function: the regulation of ESC pluripotency and differentiation. After 9 days of in vitro differentiation, the deletion of RYBP caused abnormalities in the development of embryoid bodies (EBs) as evidenced by the absence of central cavities ( Figure 6A ), which were present in 51.1 ± 22.2% of control but only 5.2 ± 6.6% of RYBP knockdown ESCs ( Figure 6B ). Knockdown of RYBP did not seem to impact the pluripotent state of the ESCs, as judged by expression levels of pluripotency markers ( Figure 6C , top) but instead inhibited the induction of specific differentiation markers, especially of the endodermal and mesodermal lineage (e.g., Gata4, Gata6, Mixl1, and Brachyury) ( Figure 6C, bottom) . No difference was observed in the expression levels of Fgf5 and Nestin, two ectoderm markers ( Figure 6C, bottom) . This is consistent with the deficiency in central cavity formation during EB development from RYBP knockdown ESCs (Figures 6A and  6B ) and suggests that RYBP has an important role in the transcriptional changes that occur during differentiation.
To test whether RYBP has any effect on cell proliferation, which may explain the defect in EB differentiation, RYBP was targeted for silencing by shRNA in HEK293 and ESCs. Cells deficient for RYBP displayed greatly decreased proliferative potential compared with control ( Figure 6D ). Although levels of RING1B were unchanged, knockdown of RYBP in HEK293 cells led to a dramatic reduction in H2AK119ub1 level but no changes in H3K27me3 ( Figure 6E ). Together with our finding that RYBPcontaining complexes have greater ubiquitinating activity than the canonical PRC1 ( Figure 5E ), these data suggest that RYBPcontaining PRC1 complexes are responsible for the majority of the H2AK119ub1 repressive marks on chromatin.
DISCUSSION Distinct Group of PRC1 Complexes and Functions
Great efforts have been made to identify and characterize the mammalian equivalent(s) of Drosophila PRC1 (Vidal, 2009) . However, previous studies focused on only a few subunits for biochemical purifications and genome-wide characterization. With TAP analysis of a panel of PRC1 subunits, we have identified six groups of PRC1 complexes, PRC1.1-1.6, distinguished by the presence of a different member of the PCGF family. The presence of RYBP and YAF2 defines different complex subgroups, which, at least in the case of PRC1.2 and PRC1.4, exclude the presence of other subunits such as CBXs, SCMs, and PHCs. ChIP-seq revealed differences in the distribution of the analyzed PRC1 complexes in the promoter regions of annotated genes, suggesting distinct chromatin targets and biological functions for each PRC1 group, which is further supported by GO enrichment analysis of their target genes. Interestingly, PCGF5 targets were enriched for GO terms associated with neuronal functions ( Figure 2C ). Given that PCGF5 also copurifies with proteins implicated in brain function, such as AUTS2, we speculate that PRC1.5 may have a specialized role in the brain.
The Recruitment Mechanisms of PRC1 Complexes
The mechanism of the recruitment of mammalian PRC1 to target genes remains one of the fundamental questions in the field. In Drosophila, PREs function as cis-acting DNA sequences for recruitment of PRC1 and PRC2, which also requires trans-acting DNA binding factors, such as pleiohomeotic (Pho) (Simon and Kingston, 2009 ). The genomic distribution of Pho overlaps substantially with that of PRC1 and PRC2, suggesting an important role in PRC1 and PRC2 recruitment (Kwong et al., 2008; Oktaba et al., 2008; ). Yet, despite the recent identification of two PRE-like elements in the (B) Quantification of the percentage of EBs showing central cavities in control or RYBP knockdown TT2 cells. Mean percentages and standard deviations were obtained from four independent experiments for each group. P-value was calculated using a two-sample one-sided t test. The insert shows the efficiency and specificity of RYBP knockdown. mammalian genome (Sing et al., 2009; Woo et al., 2010) , the role of the mammalian homolog of Pho, YY1, in PRC1 recruitment and function is far less clear than in flies. Several models exist to explain how PRC1 and PRC2 are recruited to their target sites in mammals, including association with specific DNA-binding factors, binding to H3K27me3, and interactions with noncoding RNAs Simon and Kingston, 2009 ). However, PRC1 has been often studied as a single entity, masking the complexity of its recruitment mechanism. With our description of different groups of PRC1 complexes with distinct genomic localizations, it becomes evident that one or more recruitment pathways must exist that differentiate among the various PRC1 groups. For example, CBX2 is targeted to genomic regions with enriched H3K27me3 and these regions are selectively co-occupied by PCGF2 or/and PCGF4 but not other PCGFs. Considering that PRC1.2 and PRC1.4 bear the closest resemblance with the canonical PRC1 complex, this observation fits well with the known link between H3K27me3 and PRC1. However, we also detected promoters bound by PCGF2 and PCGF4 that did not contain significant levels of H3K27me3, in which cases CBX2 was also missing. Taken together, these results suggest that H3K27me3 recognition is partially involved in the function of a subset of PRC1 complexes and is mostly restricted to CBX-containing PRC1.2 and PRC1.4. Thus, H3K27me3-independent mechanisms must exist for the recruitment of PRC1.1, 1.3, 1.5, and 1.6, as well as PRC1.2 and 1.4 devoid of CBXs. We recently showed that PRC1.6 occupies E2F6 binding sites (Trojer et al., 2011) . Thus, it would be interesting to test the role of other transcription factors and cofactors in recruiting PRC1 complexes. For example, MAX and MGA are associated with a subset of PRC1.6 complexes and they may recruit PRC1.6 to some target genes. In the case of PRC1.1, it is likely that BCL6 binding to target sequences may recruit a subset of PRC1.1 through the interaction of BcoR or BcoRL1 with BCL6 (Gearhart et al., 2006) . Another potential mechanism for PRC1 recruitment is via RYBP/YAF2-YY1 interactions. Indeed, a recent study identified a region between HOXD11 and HOXD12 as a mammalian PRE, where a cluster of cis-acting YY1 binding sites and RYBP contribute to the recruitment of PcG proteins (Woo et al., 2010) . Because we could not detect a stable association of YY1 with PRC1 in our study, it is possible that the interaction between YY1 and RYBP/YAF2 or other PRC1 components may be transient or require prior binding of YY1 to chromatin. Yet, the majority of the PRC1 complexes analyzed here lack polypeptides known to interact with sequence-specific DNA binding proteins. Given that noncoding RNAs interact with at least one PRC1 component (Yap et al., 2010) and that the EZH2 subunit of PRC2 interacts with noncoding RNAs (Margueron and Reinberg, 2011) , we suggest that diverse mechanisms operate to recruit PRC1 complexes to target genes.
RYBP/YAF2-Containing and CBXs/PHCs/SCMsContaining PRC1 Complexes Our TAPs ( Figure 1A ) and glycerol gradient analysis ( Figures 4A  and S2 ) unveiled a unique type of PRC1 complexes that contains RYBP or YAF2 along with RING1A/B and one of the six PCGFs. We demonstrate that RYBP/YAF2 forms stable ternary complexes with RING1B and each PCGF and that this association prevents binding of other common complex components, at least in the case of PRC1.2 and PRC1.4. In PRC1.4, RYBP and YAF2 are mutually exclusive with CBX, PHC, and SCM proteins ( Figures 1A and 4) , components of the canonical PRC1 complex identified previously (Levine et al., 2002) . Although both RYBPand CBX-containing versions of PRC1.4 compact chromatin in vitro, the presence of RYBP has a unique stimulatory effect on the enzymatic activity on the RING1B-PCGF4 dimer, suggesting that different types of PRC1.4 may repress transcription through different mechanisms. Knockdown of RYBP led to the loss of H2AK119ub1, reinforcing our conclusion that RYBP plays a critical role in regulating the E3 activity of RING1B. Similarly, in Drosophila, the dRAF complex containing dRing, Psc, and dKdm2 is more effective in catalyzing H2AK119ub1 than the canonical PRC1 complex both in vitro and in vivo (Lagarou et al., 2008) . Although both subtypes of PRC1.2/1.4 complexes compact chromatin, the molecular mechanism may be different. It has been suggested that CBXs are responsible for chromatin compaction (Grau et al., 2010) , rather than PCGF4, one homolog of Drosophila Psc that originally showed such activity (Francis et al., 2004) . In CBX-less PRC1 complexes, RYBP may play the role to compact chromatin, possibly via its affinity to DNA (Neira et al., 2009 ). Thus, further experiments are needed to carefully examine the influence of specific associated factors on the activities of the distinct PRC1 complexes and their impact on PRC1-mediated transcriptional repression.
EXPERIMENTAL PROCEDURES
Affinity Purification, Glycerol Gradient, and Protein Identification Cells were induced by doxycycline for 24 hr. Nuclear extracts were prepared as previously described (Dignam et al., 1983) with modifications. A detailed description is in Supplemental Information.
ChIP-seq
All ChIP-seq experiments for PRC1 components were done using an HA antibody in 293T-REx cells expressing NFH-PRC1 components or endogenous antibodies in 293T-REx cells stably transfected with a control vector. The procedure is described in detail in Supplemental Information.
Lentiviral shRNAs
Packaging plasmids were cotransfected using Lipofectamine 2000 (Invitrogen) with short hairpin RNA constructs for targeting both human and mouse RYBP (Open Biosystems). Stable knockdowns in TT2 or HEK293 cells were selected with 1 mg/ml puromycin.
In Vitro Chromatin Compaction, Sucrose Gradients, and EM These experiments were performed as previously described (Trojer et al., 2007) . Briefly, reconstituted nucleosomal arrays were incubated with isolated complexes at room temperature for 35 min and then loaded onto a 4.5 ml 10%-30% sucrose gradient, followed by centrifugation at 22, 000 rpm in a SW60Ti rotor (Beckman) at 4 C for 16 hr. The resulting samples were fractionated every 330 ml and examined by agarose gel. Chromatin samples in factions of interest were fixed with 0.6% glutaraldehyde for 30 min on ice and then processed for EM as described .
In Vitro H2A Ubiquitination Assays Assays were performed as previously described (Wang et al., 2004) with modifications. Briefly, in the presence of 100 nM E1 (Boston Biochem), 500 nM UbcH5c (Boston Biochem), 10 mM HA-ubiquitin (Boston Biochem), 5 mM ATP, and 2 ml of 10 3 ubiquitination reaction buffer (500 mM Tris-HCl, pH 7.5, 50 mM MgCl 2 , 10 mM DTT), reactions were assembled with reconstituted oligonucleosomes (2.5 mg) and purified complexes or proteins in a total volume of 20 ml. After 2 hr incubation at 37 C, the reactions were stopped by boiling in SDS sample buffer and then resolved on SDS-PAGE, followed by immunoblotting.
ACCESSION NUMBERS
The NCBI GEO accession number for the ChIP-seq data reported in this paper is GSE34774.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, five figures, and four tables and can be found with this article online at doi:10.1016/j.molcel.2012.01.002.
